Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection

Yoichi Moroi, Shohei Fujita, Shuji Fukagawa, Toshihiko Mashino, Takako Goto, Teiichi Masuda, Kazunori Urabe, Kentaro Kubo, Hiromichi Matsui, Shizuko Kagawa, Yoshimitsu Kuroyanagi, Masutaka Furue

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Clinical research on allogeneic cultured dermal substitute (CDS), which was newly developed at the R&D Center for Artificial Skin of Kitasato University, has been carried out in medical centers across Japan with the support of the Millennium Project of the Ministry of Health, Labor and Welfare of Japan. Allogeneic CDS was prepared by cultivation of fibroblasts on a two-layered spongy matrix of hyaluronic acid and atelocollagen. This paper reports the clinical results of application of allogeneic CDS in 12 patients with full-thickness skin defects after surgical resection of skin tumors. In 9 of 10 patients, healthy granulation tissue developed immediately, allowing us to perform split-thickness skin grafts at an early stage. In two cases, allogeneic CDS was used to cover an expanded mesh skin graft that had been applied to treat a large ulcer, and rapid epithelization was observed. No patient developed local infection nor local tumor recurrence after treatment with CDS. The spongy matrix itself as well as the vascular endothelial growth factor (VEGF) released by the allogeneic CDS seemed to be beneficial for the treatment of intractable skin ulcers. Allogeneic CDS functions as an excellent biological dressing, and could dramatically change the treatment of intractable skin ulcers.

Original languageEnglish
Pages (from-to)172-176
Number of pages5
JournalEuropean Journal of Dermatology
Volume14
Issue number3
Publication statusPublished - May 1 2004

Fingerprint

Artificial Skin
Skin Ulcer
Neoplasms
Skin
Japan
Biological Dressings
Transplants
Granulation Tissue
Hyaluronic Acid
Vascular Endothelial Growth Factor A
Ulcer
Therapeutics
Fibroblasts
Recurrence

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. / Moroi, Yoichi; Fujita, Shohei; Fukagawa, Shuji; Mashino, Toshihiko; Goto, Takako; Masuda, Teiichi; Urabe, Kazunori; Kubo, Kentaro; Matsui, Hiromichi; Kagawa, Shizuko; Kuroyanagi, Yoshimitsu; Furue, Masutaka.

In: European Journal of Dermatology, Vol. 14, No. 3, 01.05.2004, p. 172-176.

Research output: Contribution to journalArticle

Moroi, Y, Fujita, S, Fukagawa, S, Mashino, T, Goto, T, Masuda, T, Urabe, K, Kubo, K, Matsui, H, Kagawa, S, Kuroyanagi, Y & Furue, M 2004, 'Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection', European Journal of Dermatology, vol. 14, no. 3, pp. 172-176.
Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T et al. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. European Journal of Dermatology. 2004 May 1;14(3):172-176.
Moroi, Yoichi ; Fujita, Shohei ; Fukagawa, Shuji ; Mashino, Toshihiko ; Goto, Takako ; Masuda, Teiichi ; Urabe, Kazunori ; Kubo, Kentaro ; Matsui, Hiromichi ; Kagawa, Shizuko ; Kuroyanagi, Yoshimitsu ; Furue, Masutaka. / Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. In: European Journal of Dermatology. 2004 ; Vol. 14, No. 3. pp. 172-176.
@article{4b41d8bc3b0c4919a0a2857a7f322515,
title = "Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection",
abstract = "Clinical research on allogeneic cultured dermal substitute (CDS), which was newly developed at the R&D Center for Artificial Skin of Kitasato University, has been carried out in medical centers across Japan with the support of the Millennium Project of the Ministry of Health, Labor and Welfare of Japan. Allogeneic CDS was prepared by cultivation of fibroblasts on a two-layered spongy matrix of hyaluronic acid and atelocollagen. This paper reports the clinical results of application of allogeneic CDS in 12 patients with full-thickness skin defects after surgical resection of skin tumors. In 9 of 10 patients, healthy granulation tissue developed immediately, allowing us to perform split-thickness skin grafts at an early stage. In two cases, allogeneic CDS was used to cover an expanded mesh skin graft that had been applied to treat a large ulcer, and rapid epithelization was observed. No patient developed local infection nor local tumor recurrence after treatment with CDS. The spongy matrix itself as well as the vascular endothelial growth factor (VEGF) released by the allogeneic CDS seemed to be beneficial for the treatment of intractable skin ulcers. Allogeneic CDS functions as an excellent biological dressing, and could dramatically change the treatment of intractable skin ulcers.",
author = "Yoichi Moroi and Shohei Fujita and Shuji Fukagawa and Toshihiko Mashino and Takako Goto and Teiichi Masuda and Kazunori Urabe and Kentaro Kubo and Hiromichi Matsui and Shizuko Kagawa and Yoshimitsu Kuroyanagi and Masutaka Furue",
year = "2004",
month = "5",
day = "1",
language = "English",
volume = "14",
pages = "172--176",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "John Libbey Eurotext",
number = "3",

}

TY - JOUR

T1 - Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection

AU - Moroi, Yoichi

AU - Fujita, Shohei

AU - Fukagawa, Shuji

AU - Mashino, Toshihiko

AU - Goto, Takako

AU - Masuda, Teiichi

AU - Urabe, Kazunori

AU - Kubo, Kentaro

AU - Matsui, Hiromichi

AU - Kagawa, Shizuko

AU - Kuroyanagi, Yoshimitsu

AU - Furue, Masutaka

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Clinical research on allogeneic cultured dermal substitute (CDS), which was newly developed at the R&D Center for Artificial Skin of Kitasato University, has been carried out in medical centers across Japan with the support of the Millennium Project of the Ministry of Health, Labor and Welfare of Japan. Allogeneic CDS was prepared by cultivation of fibroblasts on a two-layered spongy matrix of hyaluronic acid and atelocollagen. This paper reports the clinical results of application of allogeneic CDS in 12 patients with full-thickness skin defects after surgical resection of skin tumors. In 9 of 10 patients, healthy granulation tissue developed immediately, allowing us to perform split-thickness skin grafts at an early stage. In two cases, allogeneic CDS was used to cover an expanded mesh skin graft that had been applied to treat a large ulcer, and rapid epithelization was observed. No patient developed local infection nor local tumor recurrence after treatment with CDS. The spongy matrix itself as well as the vascular endothelial growth factor (VEGF) released by the allogeneic CDS seemed to be beneficial for the treatment of intractable skin ulcers. Allogeneic CDS functions as an excellent biological dressing, and could dramatically change the treatment of intractable skin ulcers.

AB - Clinical research on allogeneic cultured dermal substitute (CDS), which was newly developed at the R&D Center for Artificial Skin of Kitasato University, has been carried out in medical centers across Japan with the support of the Millennium Project of the Ministry of Health, Labor and Welfare of Japan. Allogeneic CDS was prepared by cultivation of fibroblasts on a two-layered spongy matrix of hyaluronic acid and atelocollagen. This paper reports the clinical results of application of allogeneic CDS in 12 patients with full-thickness skin defects after surgical resection of skin tumors. In 9 of 10 patients, healthy granulation tissue developed immediately, allowing us to perform split-thickness skin grafts at an early stage. In two cases, allogeneic CDS was used to cover an expanded mesh skin graft that had been applied to treat a large ulcer, and rapid epithelization was observed. No patient developed local infection nor local tumor recurrence after treatment with CDS. The spongy matrix itself as well as the vascular endothelial growth factor (VEGF) released by the allogeneic CDS seemed to be beneficial for the treatment of intractable skin ulcers. Allogeneic CDS functions as an excellent biological dressing, and could dramatically change the treatment of intractable skin ulcers.

UR - http://www.scopus.com/inward/record.url?scp=2942538105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942538105&partnerID=8YFLogxK

M3 - Article

C2 - 15246944

AN - SCOPUS:2942538105

VL - 14

SP - 172

EP - 176

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 3

ER -